Disruptions in TGFβ1 signaling, particularly through its effects on Smad proteins and interactions with pathways such as MAPK and PI3K, have been linked to neurodegenerative diseases and cognitive impairments.21 The gene discussed is TGFB1; the disease is Cognitive impairment.